Report Detailing Structure, Issuance Data Of JHF Structured Notes Updated For 2008 Apr 08

  • ID: 2049443
  • April 2008
  • Standard & Poors
1 of 3

TOKYO (Standard & Poor's) April 21, 2008--Standard & Poor's Ratings Services today published a Japanese-language report detailing the updated structure and issuance data for Japan Housing Finance Agency's structured notes. On April 1, 2007, Japan Housing Finance Agency (JHF; AA/Stable/--), an incorporated administrative agency, was established to inherit the receivables and obligations held by the former Government Housing Loan Corp. (GHLC), as well as GHLC's operations. GHLC began issuing regular residential mortgage-secured pass-through notes in March 2001, and its Series S notes in August 2005. With GHLC having issued 53 series of regular notes and 10 series of Series S notes, its total issuance amount stood at about -5.8 trillion as of March 31, 2007. From April 2007, JHF inherited...

Companies mentioned in this report are: Japan Housing Finance Agency
Action: General Comment

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Japan Housing Finance Agency

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.